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Background: Postoperative readmission, recently identiﬁed as a marker of hospital quality in the Affordable Care Act,
is associated with increased morbidity, mortality, and health care costs, yet data on readmission after lower extremity
amputation (LEA) are limited. We evaluated risk factors for readmission and postdischarge adverse events after LEA in
the American College of Surgeons National Surgical Quality Improvement Program (NSQIP).
Methods: All patients undergoing transmetatarsal (TMA), below-knee (BKA), or above-knee amputation (AKA) in the
2011-2012 NSQIP were identiﬁed. Independent predischarge predictors of 30-day readmission were determined by
multivariable logistic regression. Readmission indication and reinterventions, available in the 2012 NSQIP only, were
also evaluated.
Results: We identiﬁed 5732 patients undergoing amputation (TMA, 12%; BKA, 51%; AKA, 37%). Readmission rate
was 18%. Postdischarge mortality rate was 5% (TMA, 2%; BKA, 3%; AKA, 8%; P < .001). Overall complication rate was
43% (in-hospital, 32%; postdischarge, 11%). Reoperation was for wound-related complication or additional amputation in
79% of cases. Independent predictors of readmission included chronic nursing home residence (odds ratio [OR], 1.3; 95%
conﬁdence interval [CI], 1.0-1.7), nonelective surgery (OR, 1.4; 95% CI, 1.1-1.7), prior revascularization/amputation
(OR, 1.4; 95% CI, 1.1-1.7), preoperative congestive heart failure (OR, 1.7; 95% CI, 1.2-2.4), and preoperative dialysis
(OR, 1.5; 95% CI, 1.2-1.9). Guillotine amputation (OR, 0.6; 95% CI, 0.4-0.9) and non-home discharge (OR, 0.7; 95%
CI, 0.6-1.0) were protective of readmission. Wound-related complications accounted for 49% of readmissions.
Conclusions: Postdischarge morbidity, mortality, and readmission are common after LEA. Closer follow-up of high-risk
patients, optimization of medical comorbidities, and aggressive management of wound infection may play a role in
decreasing readmission and postdischarge adverse events. (J Vasc Surg 2014;60:1315-24.)2With internal reports from the Centers for Medicare
and Medicaid Services (CMS) estimating potentially
preventable hospital readmission costs in the billions of
dollars,1 hospital readmission has become a signiﬁcant
area of interest for both policy makers and clinicians. As
we are now in the midst of the implementation of the
Affordable Care Act, CMS is rolling out the Hospital Read-
mission Reduction Program. This program implements a
payment algorithm by which hospital reimbursement will
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://dx.doi.org/10.1016/j.jvs.2014.05.050rates. According to these recommendations, hospitals
with high risk-adjusted rehospitalization rates will receive
lower average per-case payments. This has led to increased
interest in studying rehospitalization rates and contributing
factors, as indicated by a nearly threefold increase (509 to
1326) in “readmission”-related scholarly articles on www.
pubmed.gov since 2007.
Vascular surgery, in particular, has come to the
forefront of readmission investigations related to a 2009
New England Journal of Medicine study whereby 24% of
Medicare beneﬁciaries operated on for peripheral vascular
disease were readmitted, third highest of any diagnosis-
related group.3 Accordingly, recent studies have used
data from individual institutions as well as from regional
and national sources to identify the incidence of and risk
factors for readmission after either open or endovascular
lower extremity revascularization.4-7 Thus, whereas these
studies and others comparing reintervention rates after
lower extremity revascularization have been common,8,9
lower extremity amputation (LEA) has not been the subject
of similar research.
Despite our growing armamentarium for the treatment
of lower extremity arterial disease and recent improve-
ments in limb salvage rates,10 LEA is still frequently
performed, with an estimated two million Americans1315
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studies have demonstrated the signiﬁcant commitment of
long-term health care resources to patients after LEA, with
most of these patients undergoing multiple rehospitaliza-
tions during a period of months to years.12,13 Yet, despite
these inquiries into the long-term resource utilization of
patients after LEA, perioperative (#30-day) readmission
has not been studied in detail. We now aim to use the
American College of Surgeons National Surgery Quality
Improvement Program (NSQIP) database to study the
incidence of and risk factors for readmission in patients
undergoing LEA.
METHODS
Data source. We used data from the 2011 and 2012
NSQIP, a national, prospectively collected clinical database
including more than 300 institutions. Details of data
collection and quality control have been previously
described.14,15 In 2011, the NSQIP introduced a variable
for readmission within 30 days of surgery to any hospital,
including non-NSQIP hospitals, as determined by medical
record review and direct patient contact. For this reason,
analysis was restricted to 2011 and 2012 only. The accu-
racy of NSQIP readmission data was compared with that of
physician chart review and administrative data and found
to be excellent.16 Whereas the NSQIP began capture of
30-day readmission in 2011, the indication for readmission
only became available in the 2012 NSQIP. Thus, read-
mission indication is available for 2012 only. As this study
contained only de-identiﬁed data without any protected
health information, the study is not considered human
research and therefore not subject to Institutional Review
Board approval.
Patients. Patients undergoing major LEAdabove-
knee amputation (AKA), below-knee amputation (BKA),
or transmetatarsal amputation (TMA)dwere identiﬁed by
query of the 2011 and 2012 NSQIP Participant User Files
by the following Current Procedural Terminology codes:
27590, 27591, 27592, 27596, 27880, 27881, 27882, and
28805. Patients admitted to an NSQIP-participating
institution for an index trauma are speciﬁcally excluded
from the database in the context of that admission. Baseline
patient demographics, comorbidities, operative details, and
postoperative course were extracted from the database.
Patients not at risk for readmission within 30 days of index
amputation due to death during index admission or hos-
pital stay longer than 30 days were excluded from analysis.
Outcomes. Our primary outcome measure was overall
readmission to any hospital within 30 days of index ampu-
tation. Readmissions for 2012 were further categorized as
planned vs unplanned and related to the index procedure
or unrelated to the index procedure. Planned readmissions
were determined by whether the readmission was planned
at the time of the index amputation. Readmissions were
deemed related to the primary procedure if considered
related by the NSQIP reviewer. Data regarding time to
readmission, multiple readmissions, readmission indication,
and reinterventions occurring on readmission were alsonoted for 2012 when these parameters were introduced
to the NSQIP database. Secondary outcome measures
included overall 30-day morbidity and mortality stratiﬁed
as either before or after discharge.
Measures and terms. Whereas deﬁnitions for all
NSQIP terms may be found in the NSQIP user guide, this
study also used newly created terms deﬁned here. Any
wound complication refers to a composite variable inclusive
of any NSQIP-deﬁned surgical site infection (SSI) including
superﬁcial SSI, deep SSI, organ space SSI, and dehiscence.
Statistical analysis. All analyses were conducted with
IBM SPSS Statistics version 21.0.0 for Macintosh (IBM
Corp, Armonk, NY). Categorical variables were analyzed
by the c2 or Fisher exact test where appropriate. Contin-
uous variables were compared by two-tailed independent
samples t-test or analysis of variance. Cases missing data for
any given parameter were eliminated from consideration
for the purposes of bivariate analysis. Multiple logistic
regression was performed to determine independent
predictors of readmission. All variables with a P value < .10
on bivariate analysis were included in the model. Models
were then constructed by two methods; (1) one in which
any cases missing data for a candidate predictor were
excluded, and (2) one in which any cases missing data had
the missing parameter set to the reference group for that
parameter. Method A uses only cases with complete data
for candidate predictors at the cost of limited sample size.
Method B maximizes sample size but produces conserva-
tive estimates. Clinical judgment was used to eliminate
redundant variables such as emergent case status, which
was largely represented by elective case status, a more
informative variable in this context. Similarly, American
Society of Anesthesiologists (ASA) class was eliminated as it
serves as a proxy for other comorbidities represented in the
model. Length of stay was eliminated from consideration
related to the inherent bias associated with length of stay as
collected by the NSQIP. As the NSQIP follow-up period is
30 days from the date of surgery, increased length of stay
decreases the time at risk for readmission. Backward step-
wise elimination was used to determine ﬁnal independent
predictors with variables eliminated for P value > .05.
Model discrimination was assessed by C statistics, with a C
statistic of 1.0 denoting perfect predictive power and a C
statistic of .5 denoting prediction equivalent to random
chance. Hosmer-Lemeshow test was used to assess model
calibration. Spearman r was used to assess the correlation
of predicted readmission probability between the two
model methods. Throughout all analyses, statistical signif-
icance was determined by a criterion of P < .05.
RESULTS
Demographics and clinical details. Overall, 6571
patients underwent LEA in the 2011-2012 NSQIP: 2486
AKA (38%), 3310 BKA (50%), 775 TMA (12%). Exclu-
sions were made for patients not at risk for 30-day read-
mission at the time of discharge (death on index admission,
n ¼ 298 [5%], or in the hospital at 30 days, n ¼ 269 [4%])
and those for whom readmission data were unavailable
Table I. Demographic characteristics and comorbidities of lower extremity amputation (LEA) patients undergoing
readmission analysis in the 2011-2012 National Surgical Quality Improvement Program (NSQIP)
All,
No. (%)
TMA,
No. (%)
BKA,
No. (%)
AKA,
No. (%) P value
No. 5732 (100) 700 (12) 2909 (51) 2123 (37) d
Mean age 6 SD, years 66.9 6 13.6 63.6 6 13.2 64.5 6 13.3 70.9 6 13.2 <.001
Male 3650 (64) 494 (71) 1952 (67) 1204 (57) <.001
Race .001
White 3562 (65) 410 (62) 1849 (67) 1303 (64)
Black 1535 (28) 186 (28) 735 (27) 614 (30)
Asian 89 (2) 11 (2) 36 (1) 42 (2)
Native American 31 (1) 5 (1) 20 (1) 6 (0)
Native Hawaiian/Paciﬁc Islander 33 (1) 6 (1) 20 (1) 7 (0)
Chronic nursing home residence 1035 (18) 61 (9) 376 (13) 598 (28) <.001
Dependent functional status 2296 (40) 173 (25) 988 (34) 1135 (54) <.001
Diabetes mellitus 3663 (64) 526 (75) 2054 (71) 1083 (51) <.001
Smoker within last year 1535 (27) 163 (23) 789 (27) 583 (28) .081
Chronic obstructive pulmonary disease 657 (12) 49 (7) 305 (11) 303 (14) <.001
Congestive heart failure within 30 days 371 (7) 39 (6) 194 (7) 138 (7) .569
History of myocardial infarction last 6 months 107 (4) 12 (3) 59 (4) 36 (4) .414
History of prior percutaneous coronary intervention 461 (17) 68 (17) 245 (18) 148 (15) .102
History of prior cardiac surgery 599 (21) 76 (19) 312 (23) 211 (21) .229
History of revascularization or amputation 1691 (61) 249 (62) 837 (61) 605 (60) .604
Rest pain/gangrene 1676 (60) 232 (58) 837 (61) 607 (60) .576
Preoperative open wound 3971 (69) 512 (73) 2073 (71) 1386 (65) <.001
Dialysis dependence 1062 (19) 126 (18) 609 (21) 327 (15) <.001
Preoperative sepsis <.001
SIRS 713 (12) 43 (6) 352 (12) 318 (15)
Sepsis 731 (13) 407 (14) 407 (14) 213 (10)
Septic shock 111 (2) 62 (2) 62 (2) 42 (2)
ASA class $4 2314 (40) 187 (27) 1117 (38) 1010 (48) <.001
BMI $30 kg/m2 1750 (32) 259 (38) 1013 (36) 478 (23) <.001
AKA, Above-knee amputation; ASA, American Society of Anesthesiologists; BKA, below-knee amputation; BMI, body mass index; SD, standard deviation;
SIRS, systemic inﬂammatory response syndrome; TMA, transmetatarsal amputation.
All percentages reﬂect valid denominator given missing data.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 5 Curran et al 1317(n ¼ 272 [4%]). The remaining 5732 patients formed the
basis for our study. Comorbidities are outlined in Table I,
which demonstrates an increasing burden of comorbid
illness with proximal amputation. Operative and post-
operative course are discussed with readmission analysis.
Discharge was to home in 27% of cases, with the remainder
discharged to skilled or unskilled facilities, although
discharge to home varied by amputation level (home
discharge: TMA 54%, BKA 23%, AKA 23%; P < .001).
Morbidity and mortality. The 30-day morbidity and
mortality stratiﬁed by amputation level and predischarge
and postdischarge occurrence are displayed in Table II.
For those patients who died within 30 days of surgery but
after hospital discharge (n ¼ 266), mean days from
discharge until death were 10.9 (standard deviation
[SD] 6 7.0). As seen in Table II, the incidence of NSQIP-
deﬁned postdischarge adverse events varied by amputation
level. Mortality increased with proximal amputation, as did
several infectious complications including sepsis, pneu-
monia, and urinary tract infection. The proportion of
patients with multiple NSQIP-deﬁned complications also
varied by amputation level, both before and after discharge.
Morbidity and mortality are presented stratiﬁed by
readmission status and predischarge and postdischarge
occurrence in Table III. Temporal distribution ofcomplications varied according to the speciﬁc complication.
SSIs were more than four times more likely to occur after
discharge than before discharge (5% vs 1%), although all
other NSQIP-documented complications occurred more
frequently before discharge. Speciﬁcally, individual postdi-
scharge wound complications were documented as occur-
ring at a mean of 12 to 15 days (SD 6 6) after discharge
from the acute care setting.
Bivariate analysisdreadmission. Overall readmission
rate was 18%. Mean days from discharge to readmission
were 11 (SD 6 7). Three percent of readmitted patients
(n ¼ 16 of 465; 2012 only) were readmitted a second
time. Factors associated with readmission on bivariate anal-
ysis were primarily patient related (Table IV). Operative
details are listed in Table V, with elective surgery and
guillotine amputation showing a protective effect from
readmission. Further investigation showed that guillotine
amputation was associated with a decreased incidence of
postdischarge wound infection (2% vs 5%; P ¼ .002). New
dialysis dependence and unplanned reintubation on index
admission were the lone predischarge complications to
predict readmission (Table III). Given the expectation
that many guillotine amputations may have a planned
return to the operating room for wound revision,
we evaluated the risk of readmission after reoperation
Table II. Overall, predischarge, and postdischargea adverse events by amputation level in patients undergoing
readmission analysis in the 2011-2012 National Surgical Quality Improvement Program (NSQIP)
TMA,
No. (%)
BKA,
No. (%)
AKA,
No. (%) P value
Mean length of stay 6 SD, days 8.2 6 6.6 7.5 6 5.0 6.7 6 4.8 .001
Readmission 119 (17) 527 (18) 369 (17) .694
Any complication 270 (39) 1271 (44) 905 (43) .049
Predischarge 170 (24) 952 (33) 699 (33) <.001
Postdischarge 65 (9) 320 (11) 227 (11) .419
Any wound complication 84 (12) 233 (8) 142 (7) <.001
Predischarge 13 (2) 29 (1) 22 (2) .137
Postdischarge 31 (4) 163 (6) 87 (4) .042
Postdischarge mortality 11 (2) 87 (3) 168 (8) <.001
Myocardial infarction 5 (1) 45 (2) 28 (1) .228
Predischarge 4 (1) 32 (1) 15 (1) .215
Postdischarge 1 (0) 13 (0) 13 (1) .280
New dialysis dependence 10 (1) 34 (1) 15 (1) .148
Predischarge 9 (1) 29 (1) 12 (1) .121
Postdischarge 1 (0) 5 (0) 3 (0) .959
Sepsis 31 (4) 142 (5) 155 (7) <.001
Predischarge 20 (3) 82 (3) 80 (4) .145
Postdischarge 11 (2) 60 (2) 75 (4) .001
Pneumonia 13 (2) 82 (3) 78 (4) .034
Predischarge 8 (1) 38 (1) 35 (2) .484
Postdischarge 3 (0) 25 (1) 29 (1) .055
Urinary tract infection 8 (1) 108 (4) 107 (5) <.001
Predischarge 3 (0) 38 (1) 45 (2) .003
Postdischarge 2 (0) 23 (1) 29 (1) .018
Any return to operating roomb 110 (16) 324 (11) 118 (6) <.001
Unplanned predischarge reoperationc 28 (9) 62 (4) 25 (2) <.001
Unplanned postdischarge reoperationc 21 (7) 76 (5) 33 (3) .010
Any reoperation, guillotine only N/A 63 (16) 5 (5) .003
Any reoperation, non-guillotine only N/A 261 (10) 113 (6) <.001
Multiple complications 55 (8) 304 (11) 264 (12) .002
Predischarge 23 (3) 147 (5) 124 (6) .028
Postdischarge 8 (1) 64 (2) 73 (3) .001
AKA, Above-knee amputation; BKA, below-knee amputation; N/A, not applicable; SD, standard deviation; TMA, transmetatarsal amputation.
aPredischarge and postdischarge distinction is not applied when exact date of the event is unknown.
b2011 and 2012 patients.
c2012 patients only.
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tion patients (Table III).
Multivariable analysisdreadmission. Independent
predictors of readmission as determined through the model
techniques outlined in the Methods section are shown in
Fig 1. Predictors were generally patient related but also
included nonelective surgery, non-home discharge, and
postoperative new dialysis dependence. Non-home
discharge was associated with a higher baseline comor-
bidity burden (home discharge ASA class 4, 28%; non-
home discharge ASA class 4, 45%; P < .001) and
increased incidence of predischarge complications (home
discharge, 23%; non-home discharge, 35%; P < .001). The
model depicted in Fig 1, A, excluding any patient with
missing data, included a sample size of 2712, of which 480
were readmitted. The model in Fig 1, B, included all
patients. The readmission rate of 18% (n ¼ 480 of 2712)
for the patients in the exclusionary model did not differ
from the overall readmission rate (P ¼ 1.000), also 18%,
suggesting that these patients were a representative sample
with respect to readmission. Model discrimination is asshown by the C statistics demonstrated in the ﬁgure. The
Hosmer-Lemeshow test for each model was nonsigniﬁcant.
For those patients included in both models (n ¼ 2712),
the Spearman r correlating predicted probability of read-
mission was .836.
Reoperation detailsd2012 only. In the 2012
NSQIP, 115 patients (n ¼ 115 of 2874; 4%) underwent
128 predischarge reoperations on their index admission.
Approximately 70% of these patients returned to the oper-
ating room for either additional amputation (n ¼ 54 of
115; 47%) or wound-related procedures (n ¼ 28 of 115;
24%), including débridement, incision and drainage, and
revision. An additional 11% underwent either open or
endovascular revascularization (n ¼ 13 of 115). In the
2012 NSQIP, 130 patients (n ¼ 130 of 2874; 5%)
underwent 150 reoperations after discharge. One in four
readmitted patients (n ¼ 112 of 465) had a postdischarge
return to the operating room. Similar to predischarge
reoperation, wound-related procedures (n ¼ 50 of 130;
38%) and additional amputations (n ¼ 61 of 130; 47%)
accounted for the majority of postdischarge reoperations.
Table III. Overall, predischarge, and postdischargea adverse events by readmission status in lower extremity amputation
(LEA) patients who underwent readmission analysis in the 2011-2012 National Surgical Quality Improvement Program
(NSQIP)
Overall,
No. (%)
Readmitted,
No. (%)
Not readmitted,
No. (%) P value
No. 5732 (100) 1015 (18) 4717 (82) d
Mean length of postoperative stay 6 SD, days 7.3 6 5.2 6.8 6 4.4 7.4 6 5.4 <.001
Any NSQIP complication 2446 (43) 724 (71) 1722 (37) <.001
Predischarge 1821 (32) 340 (34) 1481 (31) .194
Postdischarge 612 (11) 440 (43) 172 (4) <.001
Any wound complication 459 (8) 248 (24) 211 (5) <.001
Predischarge 64 (1) 11 (1) 53 (1) 1.000
Postdischarge 281 (5) 180 (18) 101 (2) <.001
Postdischarge mortality 266 (5) 96 (10) 170 (4) <.001
Myocardial infarction 78 (1) 33 (3) 45 (1) <.001
Predischarge 51 (1) 9 (1) 42 (1) 1.000
Postdischarge 27 (1) 24 (2) 3 (0) <.001
New dialysis dependence 59 (1) 24 (2) 35 (1) <.001
Predischarge 50 (1) 15 (2) 35 (1) .038
Postdischarge 9 (0) 9 (1) 0 (0) <.001
Sepsis 328 (6) 162 (16) 166 (4) <.001
Predischarge 182 (3) 33 (3) 149 (3) .844
Postdischarge 146 (3) 129 (13) 17 (0) <.001
Pneumonia 173 (3) 78 (8) 95 (2) <.001
Predischarge 81 (1) 18 (2) 63 (1) .304
Postdischarge 57 (1) 51 (5) 6 (0) <.001
Unplanned reintubation 120 (2) 59 (6) 61 (1) <.001
Predischarge 75 (1) 22 (2) 53 (1) .014
Postdischarge 45 (1) 37 (4) 8 (0) <.001
Urinary tract infection 223 (4) 89 (9) 134 (3) <.001
Predischarge 86 (2) 20 (2) 66 (1) .199
Postdischarge 54 (1) 34 (3) 20 (0) <.001
Any return to operating roomb 570 (18) 310 (48) 260 (10) <.001
Unplanned predischarge reoperationc 115 (4) 22 (5) 93 (4) .367
Unplanned postdischarge reoperationc 130 (5) 112 (24) 18 (1) <.001
Unplanned predischarge reoperation (nonguillotine only)c 67 (3) 14 (4) 53 (3) .413
SD, Standard deviation.
aPredischarge and postdischarge distinction is not applied when exact date of the event is unknown.
b2011 and 2012 patients.
c2012 patients only.
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(n ¼ 3 of 150; 2%).
Readmission indicationd2012 only. In the 2012
NSQIP, 465 patients were readmitted, of which 451 read-
missions (97%) were unplanned. Of the unplanned read-
missions, half (n ¼ 227 of 451) were considered related
to the index amputation. TMA patients had the highest
proportion of related readmissions (65%) compared with
BKA (49%) and AKA (49%) (P ¼ .219). The readmission
indications given by the NSQIP for the unplanned, related
readmissions (n ¼ 227) are presented in Fig 2. The non-
NSQIP-deﬁned wound-related indications include wound
infections not meeting NSQIP diagnostic criteria for
infection as well as other noninfectious wound complica-
tions, such as nonhealing wound and hematoma. Including
both NSQIP-deﬁned and non-NSQIP-deﬁned wound
complications, these accounted for half of all readmissions
(49%). Those patients readmitted with peripheral vascular
disease complications include indications such as lower
extremity ulcer, gangrene, and cellulitis. Readmission
indication varied by amputation level. The proportion ofreadmitted patients readmitted for non-wound-related
infectious indication increased with proximal amputation
(TMA, 14%; BKA, 20%; AKA, 35%; P ¼ .020). Although
not reaching statistical signiﬁcance, a greater proportion of
patients were readmitted for a wound-related indication
with distal amputation (TMA, 62%; BKA, 54%; AKA, 44%;
P ¼ .197). Patients readmitted for wound complications
were more likely to undergo additional amputation than
were patients readmitted for other indications (33% vs 6%;
P < .001). Peripheral vascular disease readmissions
decreased with proximal amputation (TMA, 62%; BKA,
54%; AKA, 44%; P ¼ .222). Readmission indications for
the unplanned, unrelated readmissions are unavailable in
the NSQIP database.
DISCUSSION
This study represents the ﬁrst investigation of a
national, multicenter, prospective clinical database to eval-
uate risk factors for readmission after LEA. Readmission
after LEA is extremely common, with nearly one in ﬁve
patients undergoing LEA in the 2011-2012 NSQIP
Table IV. Bivariate comparison of preoperative characteristics for readmitted and non-readmitted lower extremity
amputation (LEA) patients in the 2011-2012 National Surgical Quality Improvement Program (NSQIP)
Overall,
No. (%)
Readmitted,
No. (%)
Not readmitted,
No. (%) P value
No. 5732 (100) 1015 (18) 4717 (82) d
Mean age 6 SD, years 67.7 6 13.6 67.4 6 13.8 66.7 6 13.6 .135
Male 3650 (64) 634 (63) 3016 (64) .368
Race .007
White 3562 (65) 637 (65) 2925 (65)
Black 1535 (28) 299 (30) 1236 (28)
Asian 89 (2) 11 (1) 78 (2)
Native American 31 (1) 6 (1) 25 (1)
Native Hawaiian/Paciﬁc Islander 33 (1) 5 (1) 28 (1)
Chronic nursing home residence 1035 (18) 219 (22) 816 (17) .001
Dependent functional status 2296 (40) 458 (46) 1838 (39) <.001
Diabetes mellitus 3663 (64) 666 (66) 2997 (64) .221
Smoker within last year 1535 (27) 260 (26) 1275 (27) .369
Chronic obstructive pulmonary disease 657 (12) 138 (14) 519 (11) .022
Congestive heart failure within 30 days 371 (7) 92 (9) 279 (6) <.001
History of myocardial infarction last 6 months 107 (4) 18 (4) 89 (4) .898
History of prior percutaneous coronary intervention 461 (17) 92 (19) 369 (16) .183
History of prior cardiac surgery 599 (21) 120 (24) 479 (21) .117
History of revascularization or amputation 1691 (61) 332 (67) 1359 (59) .002
Rest pain/gangrene 1676 (60) 329 (66) 1347 (59) .002
Preoperative open wound 3971 (69) 709 (70) 3262 (69) .680
Dialysis dependence 1062 (19) 256 (25) 806 (17) <.001
Preoperative sepsis .158
SIRS 713 (12) 147 (15) 566 (12)
Sepsis 731 (13) 131 (13) 600 (13)
Septic shock 111 (2) 21 (2) 90 (2)
ASA class $4 2314 (40) 475 (47) 1839 (39) <.001
BMI $30 kg/m2 1750 (32) 304 (31) 1446 (32) .452
ASA, American Society of Anesthesiologists; BMI, body mass index; SD, standard deviation; SIRS, systemic inﬂammatory response syndrome.
All percentages reﬂect valid denominator given missing data.
Table V. Operative details for lower extremity amputation (LEA) patients who underwent readmission analysis in the
2011-2012 National Surgical Quality Improvement Program (NSQIP)
Overall,
No. (%)
Readmitted,
No. (%)
Not readmitted,
No. (%) P value
No. 5732 (100) 1015 (18) 4717 (82) d
Mean OR time 6 SD, minutes 66 6 40 66 6 35 66 6 42 .616
Amputation level .694
TMA 700 (12) 119 (12) 581 (12)
BKA 2909 (51) 527 (52) 2382 (51)
AKA 2123 (37) 369 (36) 1754 (37)
Guillotine amputation 495 (10) 58 (7) 437 (11) <.001
Emergency surgery 716 (13) 110 (11) 606 (13) .084
Elective surgery 2044 (36) 318 (32) 1726 (37) .002
AKA, Above-knee amputation; BKA, below-knee amputation; OR, operating room; SD, standard deviation; TMA, transmetatarsal amputation.
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NSQIP cohort were primarily patient related, although
nonelective surgery, non-home discharge, and postopera-
tive dialysis dependence also predicted readmission
(Fig 1). Both methods of logistic regression model con-
struction produced similar results. Readmissions were un-
planned in most cases (97%), although approximately half
of unplanned readmissions were deemed unrelated to the
index amputation. Of patients with unplanned, related
readmissions, half were related to wound complications.
Highlighting the importance of wound management inthese patients, reoperations, both before and after
discharge, were related to wound issues in approximately
a third of patients and included additional amputation in
approximately half. Finally, readmitted patients represent
an extremely high-risk population as they demonstrated a
mortality rate two and a half times that of non-
readmitted patients (10% vs 4%).
Whereas prior studies on readmission after LEA
have focused on long-term resource utilization, our study
is the ﬁrst to evaluate the incidence of perioperative
(30-day) readmission and its risk factors. Feinglass et al12
Fig 1. A, Independent predictors of readmission for lower extremity amputation (LEA) patients in the 2011-2012
National Surgical Quality Improvement Program (NSQIP); missing variables excluded. B, Independent predictors of
readmission for LEA patients in the 2011-2012 NSQIP; missing variables set to reference group. CHF, Congestive
heart failure; COPD, chronic obstructive pulmonary disease.
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undergoing LEA in the Department of Veterans Affairs
NSQIP system in the early 1990s, showing that more
than 70% of patients were readmitted during a median
follow-up period of 32 months. Similarly, Henry et al13
reported on long-term resource utilization after LEA at
two tertiary care centers, yet this study also reported a
30-day readmission rate of 20.1% (n ¼ 73 of 364). This
rate of readmission is similar to the rate found in the NSQIP
cohort (19%), showing that the issue of readmission after
LEA is relevant to tertiary referral centers as well as to others.
Given the chronic and largely nonmodiﬁable nature of
preoperative nursing home residence, congestive heart fail-
ure, chronic obstructive pulmonary disease, and dialysis
dependence, quality improvement measures focused on
these patient-related readmission risk factors are likely to
be limited. Although we may hope to medically optimize
these patients preoperatively through diuresis and medica-
tion management, substantive improvement in theirbaseline comorbidity proﬁle is often not feasible in the pre-
operative period. Non-home discharge, also a predictor of
readmission, was associated with a higher burden of preop-
erative comorbid illness and predischarge complications.
Robust primary care management of these complex
patients with early referral to vascular surgeons may limit
the proportion of amputations performed under emergent
circumstances, which could also play a role in mitigating
readmissions by allowing optimization.
With few patient-related risk factors for readmission
conducive to preoperative modiﬁcation, we look to the
indication for readmission and interventions performed
on readmission for insight into how to address this issue.
Approximately half of patients were readmitted for
wound-related complications, and one quarter of readmit-
ted patients returned to the operating room, most for
wound-related procedures or additional amputations. In
fact, patients readmitted for wound complications were
seven times more likely to undergo additional amputation
Fig 2. Unplanned related readmission indication among lower extremity amputation (LEA) patients in the 2012
National Surgical Quality Improvement Program (NSQIP) cohort.
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conjunction with a trend toward increasing wound compli-
cations with distal amputation, may suggest that surgeons
attempting to leave their patients with maximum limb
function through a limited amputation could be susceptible
to higher readmission rates. As the wound complications
and the need for reoperation are likely to relate to a num-
ber of patient and operative factors, these present several
opportunities for quality improvement. Avoidance of reop-
eration was the focus of a 2013 study by O’Brien et al17
that evaluated risk factors for early failure of LEA as indi-
cated by a return to the operating room on index admis-
sion. Using the 2005-2010 NSQIP, O’Brien et al
showed active tobacco use (odds ratio [OR], 1.18; 95%
conﬁdence interval [CI], 1.00-1.38) and intraoperative
surgical trainee participation (OR, 1.37; 95% CI, 1.20-
1.57) to increase reoperation risk, whereas locoregional
anesthesia (OR, 0.75; 95% CI, 0.63-0.89) and operating
room time longer than 40 minutes were found to be
protective.
By use of the risk factors for reoperation elucidated by
O’Brien et al, tangible steps to decrease the need for reop-
eration, and consequently readmission, are evident. A
recent meta-analysis on the beneﬁt of preoperative smoking
cessation found a 40% decrease in postoperative complica-
tions in patients who discontinued tobacco use preopera-
tively.18 Routine use of proactive smoking cessation
strategies, such as in-clinic enrollment in smoking cessation
programs during preoperative consultation, may improve
our patients’ success in this regard.19,20 Intraoperatively,
the use of locoregional anesthesia, when possible, avoids
the physiologic stress of general anesthesia and may play
a role in preventing certain systemic postoperative compli-
cations. Finally, whereas careful supervision of surgicaltrainees and a deliberate technical approach may also aid
in the avoidance of reoperation and rehospitalization, it is
difﬁcult to draw conclusions about the impact of trainee
participation on postoperative outcomes with use of the
NSQIP database, given the difﬁculty in eliminating hidden
confounders related to the selection of intraoperative
assistants.
In further evaluation of the indication for readmission
and the role it may play in readmission avoidance, readmis-
sion indication was not similarly distributed across amputa-
tion level given, probably related to baseline differences in
health status of the patients undergoing these procedures.
Patients receiving an AKA compared with a TMA in the
NSQIP cohort were nearly two times more likely to be
ASA class 4 or higher (Table I). Accordingly, AKA patients
were more likely than BKA or TMA patients to be readmit-
ted for non-wound-related infectious complications, such
as pneumonia, urinary tract infection, and sepsis. This is
in contrast to readmissions for wound complications or
complications of peripheral vascular disease, which showed
trends toward an increase in incidence with distal
amputation.
Whereas the particular care needs of LEA patients may
vary by amputation level, a preponderance of postdi-
scharge wound complications was seen for amputations
at all levels. Henry et al reported similar results at their
institutions, with 52.8% of 30-day readmissions taking
place for issues related to amputation and peripheral arte-
rial disease. Interestingly, guillotine amputations were
seen to have decreased readmission rates relative to non-
guillotine amputations, which may be attributable to a
2.5-fold increase in SSI for non-guillotine amputations.
However, guillotine amputations, whether later revised
in the operating room or allowed to heal secondarily
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patients’ return to function, and as such, this approach
must be weighed carefully. A 2011 report by Hasanadka
et al21 that reviewed the NSQIP for risk factors of SSI
found elevated preoperative international normalized ratio
and smoking status to be the lone modiﬁable risk factors
for wound infection. These ﬁndings further emphasize
the critical importance of preoperative smoking cessation
while also highlighting the necessity for excellent intrao-
perative hemostasis to avoid hematoma in this population
already at high risk for SSI.
Any discussion of readmission necessarily involves
assessment of the appropriateness of hospital length of
stay as this is thought to provide a counterbalance to the
incidence of readmission. In the NSQIP cohort, increased
length of stay was correlated with a decreased risk of read-
mission (Table III). However, given that readmissions
occurred at a mean of 11 days (SD 6 7) after discharge
and NSQIP follow-up ends at 30 days after surgery, a
longer length of stay shortens the postdischarge follow-
up for these patients, thus resulting in a decreased likeli-
hood of readmission. For this reason, length of stay was
excluded from our multivariable model. Of note, Medicare
readmission penalties are assessed for readmission within
30 days of hospital discharge, whereas the NSQIP follows
patients only for 30 days after their index operation.2,15
Thus, this data set is unable to provide accurate estimates
about the effect of hospital stay duration on readmission
risk. However, as noted in the Results section, postdi-
scharge wound infections were diagnosed, on average,
more than a week after leaving the hospital, and postdi-
scharge mortality occurred approximately 10 days after
discharge. Although this certainly argues for close postop-
erative follow-up, it is unclear whether marginal increases
in length of stay would provide a beneﬁt with respect to
the development of these complications.
The ﬁndings of this study must be interpreted in the
context of the study design. The NSQIP database provides
data de-identiﬁed at the patient, institutional, and regional
levels, which precludes the investigation of institutional and
regional variation in readmission. Future studies using
alternative data sources may provide valuable insight
through the identiﬁcation of high-performing centers and
their best practices. The database also does not include
information such as insurance type or median zip code
income to assess the impact of socioeconomic factors on
readmission. However, as a prospectively collected, multi-
center, clinical database whose methodology includes
direct patient contact within 30 days, the NSQIP database
has the particular strength of capturing readmissions to
both the operating institution and others. Whereas the
NSQIP database did collect readmission indication in
2012, it did so only for readmissions deemed related to
the index procedure, approximately half of unplanned read-
missions. As the relationship of certain systemic complica-
tions to the index procedure is highly subjective, future
iterations of the NSQIP may consider including readmis-
sion indication for all readmitted patients.CONCLUSIONS
This study represents the ﬁrst and largest report from a
multicenter clinical database on the incidence of and risk
factors for readmission after LEA. With one in ﬁve patients
rehospitalized after LEA, we have shown readmission to be
common, and given its association with a twofold increase
in mortality, we have also shown readmission to be incred-
ibly costly to our patients. Risk factors for readmission
include patient characteristics as well as the occurrence of
reoperation on index admission. Whereas indications for
readmission require further study, we have shown that a
majority of readmissions are related to wound complica-
tions. Strategies to mitigate postoperative readmission
should place particular attention on preoperative optimiza-
tion of comorbid illness with an emphasis on smoking
cessation and intraoperative factors to prevent both wound
complications and reoperation.
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